Qingxi Wang
Directeur/Membre du Conseil chez CSPC PHARMACEUTICAL GROUP LTD.
Fortune : 2 M $ au 30/04/2024
Profil
Qingxi Wang is currently the Chairman & Chief Executive Officer at Conjupro Biotherapeutics, Inc. and an Executive Director at CSPC Pharmaceutical Group Ltd.
Previously, he worked as a Director of Operations & Business Development at Merck & Co., Inc. Dr. Wang holds a Master's in Business Administration from Temple University, a graduate and doctorate degree from the University of Connecticut, and undergraduate and graduate degrees from Nankai University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
29/11/2023 | 3 000 000 ( 0,03% ) | 2 M $ | 30/04/2024 |
Postes actifs de Qingxi Wang
Sociétés | Poste | Début |
---|---|---|
CSPC PHARMACEUTICAL GROUP LTD. | Directeur/Membre du Conseil | 20/08/2018 |
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Conjupro Biotherapeutics, Inc. is a biopharmaceutical company that specializes in clinical research and drug development. The company is based in Princeton, NJ. Qingxi Wang has been the CEO of the company since 2016. | Directeur Général | 01/01/2016 |
Anciens postes connus de Qingxi Wang
Sociétés | Poste | Fin |
---|---|---|
MERCK & CO., INC. | Directeur des opérations | - |
Formation de Qingxi Wang
Temple University (Pennsylvania) | Masters Business Admin |
University of Connecticut | Doctorate Degree |
Nankai University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
CSPC PHARMACEUTICAL GROUP LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Conjupro Biotherapeutics, Inc. is a biopharmaceutical company that specializes in clinical research and drug development. The company is based in Princeton, NJ. Qingxi Wang has been the CEO of the company since 2016. | Commercial Services |